Chloroquine Phosphate Tablet
Product Images NDC 64980-177

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Chloroquine Phosphate (NDC 64980-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chloroquine Phosphate Tablets Usp 250 mg 50 Ct

Label for Chloroquine Phosphate Tablets, USP 250 mg oral tablets by Rising Pharma Holdings, Inc. The label states 50 tablets per container with usage for malaria and extraintestinal amebiasis. Manufactured by NATCO Pharma Limited, India, and Rising Pharmaceuticals, Inc., NJ. Includes barcodes, storage instructions, warnings, and lot/expiration information.*

FDA Label Image

Image (Structural Formula)

Chemical structure diagram of Chloroquine Phosphate, showing the quinoline ring with a chlorine atom and the side chain containing a nitrogen atom, along with its phosphate salt indicated as 2 H3PO4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.